Health News (Reuters)

Brain implants might one day help paralyzed patients use tablets

(Reuters Health) - - Paralyzed people might one day be able to operate smartphones and tablets just by thinking about the actions they want to perform, with help from sensors implanted in their brains, a recent experiment suggests.

Breast cancer survivors may have lingering mental health effects

(Reuters Health) - - Breast cancer survivors may be more likely to experience anxiety, depression, sleep troubles and other mental health issues than women who have not been diagnosed with the disease, a research review suggests.

Older adults may be unwilling to give up colorectal screening

(Reuters Health) - At age 76 the risks of a repeat colonoscopy may exceed the benefits for seniors whose previous screenings have found no signs of cancer, but many older adults don't like the logic behind this guideline based on life expectancy.

Roche's lung cancer combo treatment wins FDA approval

Swiss drugmaker Roche Holding AG said on Thursday that its Tecentriq immunotherapy in combination with chemotherapy was approved by the U.S. Food and Drug Administration as a first-line treatment for a form of lung cancer.

U.S. healthcare spending growth slows for second year in a row

Healthcare spending growth in the United States slowed for the second year in a row in 2017, mainly due to slower spending growth for hospital care, physician and clinical services as well as retail prescription drugs, according to a report from the U.S. Centers for Medicare and Medicaid Services.

More evidence fruits and greens can be good for the brain

(Reuters Health) - - Middle-aged men who eat lots of fruits and vegetables may be lowering their odds of cognitive problems as they get on in years, compared to peers who don't consume these foods very often, a U.S. study suggests.

'Narrative medicine' may help stem doctor burnout

(Reuters Health) - - As reports of rising levels of physician burnout and suicide accumulate, two pediatricians urge medical programs to consider using "narrative medicine" to help humanize practice and begin to treat the heavy emotional toll many doctors experience.

Supernus Pharma's ADHD treatment fails to impress; shares fall

Supernus Pharmaceuticals Inc's treatment for attention deficit hyperactivity disorder met the main goal of two trials, but shares fell about 16 percent on Thursday as the data failed to convince some investors that the drug was better than rivals.

Supernus Pharma's ADHD treatment meets main goal in two studies

Supernus Pharmaceuticals Inc on Thursday said its experimental treatment for attention deficit hyperactivity disorder met the main goal of reducing symptoms in affected children from six to 11 years of age in two late-stage studies.

Pages